Skip to main content

Advertisement

Log in

High-Sensitivity CRP in Opiate Addiction: Relative and Age-Dependent Elevations

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

High-sensitivity C-reactive protein (hs-CRP) has been shown to be linked with immune stimulation, but is not well studied over the lifetime in opiate addiction. hs-CRP was measured by standard laboratory methods in substance use disorder (SUD) patients and non-SUD (NSUD) aged 18–48 years. Data were log transformed to improve normality. 1231 SUD were compared with 326 NSUD patients of comparable ages. hs-CRP was 7.46 ± 14.24 versus 4.75 ± 13.40 mg/l (mean ± SD) significantly higher in the SUD group (P < 0.0001), a difference which persisted after exclusion of acutely elevated hs-CRP values (P < 0.0001). In multiple regression with age, addictive status was significant both by itself (P < 0.0001) and in interaction with age (P < 0.0001). At age 40 years, the SUD group had a mean hs-CRP of 3.68 which the NSUD group did not achieve till a modelled age of 157.09 years. In an interactive multivariate regression, interactions between age, addictive status, ALT and AST were significant. These data show that hs-CRP is elevated in opiate dependence both per se, and when controlled for age. Furthermore, they suggest that hs-CRP and immune stimulation seen in opiate addiction may underlie the acceleration of age-related multi-system chronic and coronary atherosclerotic disease well described in opiate dependence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yano, Y., Matsuda, S., Hatakeyama, K., Sato, Y., Imamura, T., Shimada, K., et al. (2010). Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients. The journals of gerontology. Series A, Biological sciences and medical sciences, 65, 547–552.

    Article  PubMed  Google Scholar 

  2. Agrawal, A., Singh, P. P., Bottazzi, B., Garlanda, C., & Mantovani, A. (2009). Pattern recognition by pentraxins. Advances in Experimental Medicine and Biology, 653, 98–116.

    Article  PubMed  CAS  Google Scholar 

  3. (2008). Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: The JUPITER study. Cardiovascular Journal of Africa, 19, 332–334, discussion 335.

  4. Slattery, M. L., Curtin, K., Poole, E. M., Duggan, D. J., Samowitz, W. S., Peters, U., et al. (2010). Genetic variation in C-reactive protein (CRP) in relation to colon and rectal cancer risk and survival. International Journal of Cancer, 128, 2726–2734.

    Article  Google Scholar 

  5. Chaturvedi, A. K., Caporaso, N. E., Katki, H. A., Wong, H. L., Chatterjee, N., Pine, S. R., et al. (2010). C-Reactive Protein and Risk of Lung Cancer. Journal of Clinical Oncology, 28, 2716–2726.

    Article  Google Scholar 

  6. Everett, B. M., Glynn, R. J., MacFadyen, J. G., & Ridker, P. M. (2010). Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation, 121, 143–150.

    Article  PubMed  CAS  Google Scholar 

  7. Antonescu-Turcu, A. L., & Tomic, R. (2009). C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations. Current Opinion in Pulmonary Medicine, 15, 120–125.

    Article  PubMed  CAS  Google Scholar 

  8. Kalhan, R., Tran, B. T., Colangelo, L. A., Rosenberg, S. R., Liu, K., Thyagarajan, B., et al. (2010). Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS ONE, 5, e11431.

    Article  PubMed  Google Scholar 

  9. Bafadhel, M., Clark, T. W., Reid, C., Medina, M. J., Batham, S., Barer, M. R., et al. (2010). Procalcitonin and C reactive protein in hospitalised adult patients with community acquired pneumonia, exacerbation of asthma and chronic obstructive pulmonary disease. Chest, 139, 1410–1418.

    Article  PubMed  Google Scholar 

  10. Brunton, L. L., Lazo, J. S., & Parker, K. L. (Eds.). (2006). Goodman and gilman’s the pharmacologic basis of therapeutics (11th ed.). New York: McGraw Hill.

    Google Scholar 

  11. McCarthy, L., Wetzel, M., Sliker, J. K., Eisenstein, T. K., & Rogers, T. J. (2001). Opioids, opioid receptors, and the immune response. Drug and Alcohol Dependence, 62, 111–123.

    Article  PubMed  CAS  Google Scholar 

  12. Neri, S., Bruno, C. M., Pulvirenti, D., Malaguarnera, M., Italiano, C., Mauceri, B., et al. (2005). Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers. Psychopharmacology (Berl), 179, 700–704.

    Article  CAS  Google Scholar 

  13. Reece, A. S. (2008). Clinical implications of addiction related immunosuppression. The Journal of Infection, 56, 437–445.

    Article  PubMed  Google Scholar 

  14. Cabral, G. A. (2006). Drugs of abuse, immune modulation, and AIDS. Journal of Neuroimmune Pharmacology, 1, 280–295.

    Article  PubMed  Google Scholar 

  15. Pillai, R., Nair, B. S., & Watson, R. R. (1991). AIDS, drugs of abuse and the immune system: A complex immunotoxicological network. Archives of Toxicology, 65, 609–617.

    Article  PubMed  CAS  Google Scholar 

  16. Reece, A. S. (2010). Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing. Medical Hypotheses, in press.

  17. Reece, A. S. (2009). Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy. British Medical Journal Case Reports Published 14/04/09.

  18. Reece, A. S. (2007). Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immunity and Ageing, 4, 6–15.

    Article  PubMed  Google Scholar 

  19. Wilson, N. S., Behrens, G. M., Lundie, R. J., Smith, C. M., Waithman, J., Young, L., et al. (2006). Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nature Immunology, 7, 165–172.

    Article  PubMed  CAS  Google Scholar 

  20. Xu, R. H., Remakus, S., Ma, X., Roscoe, F., & Sigal, L. J. (2010). Direct presentation is sufficient for an efficient anti-viral CD8 + T cell response. PLoS Pathogens, 6, e1000768.

    Article  PubMed  Google Scholar 

  21. Carvalho, F. (2009). How bad is accelerated senescence in consumers of drugs of abuse? Adicciones, 21, 99–104.

    PubMed  Google Scholar 

  22. Sargeant, T. J., Day, D. J., Miller, J. H., & Steel, R. W. (2008). Acute in utero morphine exposure slows G2/M phase transition in radial glial and basal progenitor cells in the dorsal telencephalon of the E15.5 embryonic mouse. The European Journal of Neuroscience, 28, 1060–1067.

    Article  PubMed  Google Scholar 

  23. Sargeant, T. J., Miller, J. H., & Day, D. J. (2008). Opioidergic regulation of astroglial/neuronal proliferation: Where are we now? Journal of Neurochemistry, 107, 883–897.

    PubMed  CAS  Google Scholar 

  24. Reece, A. S., & Davidson, P. (2007). Deficit of circulating stem–progenitor cells in opiate addiction: A pilot study. Substance Abuse Treatment, Prevention, and Policy, 2, 19–28.

    Article  PubMed  Google Scholar 

  25. Gopinath, S. D., & Rando, T. A. (2008). Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell, 7, 590–598.

    Article  PubMed  CAS  Google Scholar 

  26. Cherry, C. M., & Matunis, E. L. (2010). Epigenetic regulation of stem cell maintenance in the Drosophila testis via the nucleosome-remodeling factor NURF. Cell Stem Cell, 6, 557–567.

    Article  PubMed  CAS  Google Scholar 

  27. Kerr, C. L., & Cheng, L. (2010). Multiple, interconvertible states of human pluripotent stem cells. Cell Stem Cell, 6, 497–499.

    Article  PubMed  CAS  Google Scholar 

  28. Makela, J., Koivuniemi, R., Korhonen, L., & Lindholm, D. (2010). Interferon-gamma produced by microglia and the neuropeptide PACAP have opposite effects on the viability of neural progenitor cells. PLoS ONE, 5, e11091.

    Article  PubMed  Google Scholar 

  29. Darke, S., Kaye, S., & Duflou, J. (2006). Systemic disease among cases of fatal opioid toxicity. Addiction, 101, 1299–1305.

    Article  PubMed  Google Scholar 

  30. Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug and Alcohol Dependence, 105, 9–15.

    Article  PubMed  Google Scholar 

  31. Kim, T. W., Alford, D. P., Malabanan, A., Holick, M. F., & Samet, J. H. (2006). Low bone density in patients receiving methadone maintenance treatment. Drug and Alcohol Dependence, 85, 258–262.

    Article  PubMed  CAS  Google Scholar 

  32. Rosen, D., Smith, M. L., & Reynolds, C. F., 3rd. (2008). The prevalence of mental and physical health disorders among older methadone patients. The American Journal of Geriatric Psychiatry, 16, 488–497.

    Article  PubMed  Google Scholar 

  33. Sadeghian, S., Darvish, S., Davoodi, G., Salarifar, M., Mahmoodian, M., Fallah, N., et al. (2007). The association of opium with coronary artery disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14, 715–717.

    Article  PubMed  Google Scholar 

  34. Smyth, B., Hoffman, V., Fan, J., & Hser, Y. I. (2007). Years of potential life lost among heroin addicts 33 years after treatment. Preventive Medicine, 44, 369–374.

    Article  PubMed  Google Scholar 

  35. Darke, S., Duflou, J., & Torok, M. (2010). The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug and Alcohol Dependence, 106, 1–6.

    Article  PubMed  CAS  Google Scholar 

  36. Reece, A. S. (2007). Dentition of addiction in Queensland: Poor dental status and major contributing drugs. Australian Dental Journal, 52, 144–149.

    Article  PubMed  CAS  Google Scholar 

  37. Reece, A. S. (2007). Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program. Substance Abuse Treatment, Prevention, and Policy, 2, 35–49.

    Article  PubMed  CAS  Google Scholar 

  38. Burns, L., Randall, D., Hall, W. D., Law, M., Butler, T., Bell, J., et al. (2009). Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention. Addiction, 104, 1363–1372.

    Article  PubMed  Google Scholar 

  39. Gottshcalk L. A., McGuire F. L., Heiser J. F., Dinovo E. C., & Birch, H. (1979). Drug abuse deaths in nine cities: A survey report. (National Institute of Drug Abuse ed., vol. 29, NIDA Research Monograph,. pp. 1–189. Bethesda, Maryland, USA: National Institutes of Health), pp. 1–189.

  40. Hser, Y. I., Hoffman, V., Grella, C. E., & Anglin, M. D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503–508.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Albert Stuart Reece.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reece, A.S. High-Sensitivity CRP in Opiate Addiction: Relative and Age-Dependent Elevations. Cardiovasc Toxicol 12, 149–157 (2012). https://doi.org/10.1007/s12012-012-9154-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-012-9154-2

Keywords

Navigation